Q4 2025 Holdings
Filed 2026-02-17 | 13 holdings | $139.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $41.3M | 4,391,818 | 29.6% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $24.0M | 769,550 | 17.2% |
| Bausch Plus Lomb Corp(BLCO) | COMMON SHARES | 071705107 | $10.5M | 613,472 | 7.5% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $10.4M | 224,135 | 7.5% |
| Amgen Inc(AMGN) | COM | 031162100 | $7.6M | 23,212 | 5.4% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $7.6M | 329,101 | 5.4% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $7.3M | 1,330,901 | 5.2% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $5.6M | 930,317 | 4.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $5.5M | 66,680 | 3.9% |
| Incyte Corp(INCY) | COM | 45337C102 | $5.4M | 54,500 | 3.9% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $5.0M | 28,587 | 3.6% |
| Pyxis Oncology Inc(PYXS) | COM NEW | 747324101 | $4.7M | 4,121,870 | 3.4% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $4.6M | 170,307 | 3.3% |